Skip to main content

Zimmer Biomet company profile

  • ZBH · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$103.21−1.29%Close 13 Nov 2026

About Zimmer Biomet

Zimmer Biomet designs, manufactures and markets orthopedic reconstructive products, including knee and hip implants; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; bone cement; surgical products; and integrated digital and robotic technologies. Its customers include orthopedic surgeons, neurosurgeons, healthcare institutions, stocking distributors, healthcare dealers and healthcare purchasing organizations. Products are sold directly to hospitals and ambulatory surgery centers and through distributors and dealers. The company operates through three regional segments: the Americas, Europe, Middle East and Africa, and Asia Pacific, with the U.S. and Japan as the largest markets within the Americas and Asia Pacific segments, respectively.

A summary of the business section of the company's latest annual report, filed 20 Feb 2026.

Company facts

TickerZBH · NYSE
SectorMedical devices
IndustryHealth Care Equipment
IndexS&P 500
Fiscal year ends31 December
Reporting currencyUSD
CIK1136869
Latest annual report10-K, filed 20 Feb 2026

Officers and directors

NameRoleShares ownedLatest Form 4
Ivan TornosChairman, President and CEO · Director304K · < 1%Shares withheld for tax, 6 Mar 2026
Suketu UpadhyayExec VP, CFO260K · < 1%Shares withheld for tax, 6 Mar 2026
Wilfred van ZuilenGroup Pres, EMEA90.6K · < 1%Option exercise, 6 Mar 2026
Jehanzeb NoorSee remarks below.202 · < 1%Option exercise, 1 Apr 2026
Campbell Gary CraigPresident, Americas—Option exercise, 1 Oct 2026
Kevin ThornalGrp Pres-Global Business—Open-market sale, 11 Sep 2026
Phipps Chad FSee remarks below.—Open-market sale, 4 Sep 2026
Yi SangGroup President, Asia Pacific—Open-market sale, 29 May 2026
Winkler LoriSVP and CHRO—Open-market sale, 12 Mar 2026
Stellato Paul AVP, Controller, CAO—Option exercise, 6 Mar 2026
Bezjak MarkPresident, Americas—Shares withheld for tax, 6 Mar 2025
Ellingson RachelChief Administrative Officer—Option exercise, 20 Feb 2025

Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.

ZBH in the terminal

The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.